S
ONC

SignatureFD’s BeOne Medicines Ltd ONC Stock Holding History

SignatureFD’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
365
+45
+14% +$13.3K ﹤0.01% 1419
2026
Q1 		$95.1K Sell
320
-20
-6% -$6.47K ﹤0.01% 1377
2025
Q4 		$103K Buy
340
+33
+11% +$10.8K ﹤0.01% 1307
2025
Q3 		$105K Buy
307
+105
+52% +$31.9K ﹤0.01% 1276
2025
Q2 		$48.9K Buy
202
+54
+36% +$13.2K ﹤0.01% 1594
2025
Q1 		$40.3K Buy
148
+20
+16% +$4.68K ﹤0.01% 1700
2024
Q4 		$23.6K Buy
128
+119
+1,322% +$24.3K ﹤0.01% 1979
2024
Q3 		$2.08K Buy
9
+8
+800% +$1.44K ﹤0.01% 2826
2024
Q2 		$210 Sell
1
-9
-90% -$1.39K ﹤0.01% 3049
2024
Q1 		$1.55K Buy
10
+3
+43% +$483 ﹤0.01% 2870
2023
Q4 		$1.26K Hold
7
– – ﹤0.01% 2868
2023
Q3 		$1.26K Hold
7
– – ﹤0.01% 2889
2023
Q2 		$1.25K Sell
7
-2
-22% -$461 ﹤0.01% 2919
2023
Q1 		$1.94K Hold
9
– – ﹤0.01% 2810
2022
Q4 		$1.98K Sell
9
-19
-68% -$3.48K ﹤0.01% 2818
2022
Q3 		$4K Sell
28
-2
-7% -$343 ﹤0.01% 2583
2022
Q2 		$5K Buy
30
+10
+50% +$1.56K ﹤0.01% 2477
2022
Q1 		$4K Sell
20
-470
-96% -$99.9K ﹤0.01% 2631
2021
Q4 		$133K Sell
490
-68
-12% -$23K ﹤0.01% 890
2021
Q3 		$203K Sell
558
-77
-12% -$25.2K 0.01% 680
2021
Q2 		$218K Buy
635
+208
+49% +$68.9K 0.01% 636
2021
Q1 		$149K Buy
427
+178
+71% +$58.9K 0.01% 710
2020
Q4 		$64K Buy
249
+118
+90% +$32.5K ﹤0.01% 975
2020
Q3 		$38K Buy
131
+63
+93% +$14.8K ﹤0.01% 1101
2020
Q2 		$13K Buy
68
+60
+750% +$9.77K ﹤0.01% 1483
2020
Q1 		$1K Buy
+8
New +$1.25K ﹤0.01% 2225
2019
Q3 		– Sell
-8
Closed -$1K – 2219
2019
Q2 		$1K Buy
+8
New +$1.01K ﹤0.01% 1969

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SignatureFD's ONC Position: Q2 2026 in Review

SignatureFD increased its BeOne Medicines Ltd (ONC) stake by 14% in Q2 2026, buying an estimated $13.3K and bringing the position to 365 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

SignatureFD first reported a position in ONC in Q2 2019 and has held it in 27 quarters since. The position peaked at $218K in Q2 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • SignatureFD held 365 shares of BeOne Medicines Ltd worth $104K as of Q2 2026.
  • SignatureFD bought 45 BeOne Medicines Ltd shares in Q2 2026, an estimated $13.3K.
  • BeOne Medicines Ltd made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1419 holding.
  • SignatureFD first reported a position in BeOne Medicines Ltd in Q2 2019 and has held it in 27 quarters since.
  • SignatureFD's BeOne Medicines Ltd position peaked at $218K in Q2 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.